Soleno Therapeutics (SLNO) Share-based Compensation Growth (1y) (2014 - 2025)
Soleno Therapeutics (SLNO) Share-based Compensation Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -40.86% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -82.34% |
| Jun 30, 2025 | 35.45% |
| Sep 30, 2024 | 2,471.47% |
| Jun 30, 2024 | 494.68% |
| Mar 31, 2024 | 921.39% |
| Dec 31, 2023 | -738.61% |
| Sep 30, 2023 | 222.25% |
| Jun 30, 2023 | 110.86% |
| Mar 31, 2023 | -2.02% |
| Dec 31, 2022 | -79.97% |
| Sep 30, 2022 | -24.61% |
| Jun 30, 2022 | -33.37% |
| Mar 31, 2022 | 436.67% |
| Dec 31, 2021 | 703.05% |
| Sep 30, 2021 | 142.25% |
| Jun 30, 2021 | 151.32% |
| Mar 31, 2021 | -69.39% |
| Dec 31, 2020 | 92.65% |
| Sep 30, 2020 | 144.44% |
| Jun 30, 2020 | 55.00% |